Perimeter Medical Imaging AI shortlisted for grant funding under Biden Cancer Moonshot initiative

–News Direct–

Perimeter Medical Imaging AI CEO Adrian Mendes joined Proactive's Stephen Gunnion with news that the company has been shortlisted in a grant funding process sponsored by the Advanced Research Projects Agency for Health (ARPA-H) as part of its Precision Surgical Interventions (PSI) program.

Mendes explained that the initiative aims to provide groundbreaking tools for surgeons to effectively remove cancer in a single operation. Perimeter's technology aligns perfectly with this goal, as they have been working on it for the past decade.

Perimeter Medical Imaging AI utilizes a technology called OCT, which has been around for 30 years. However, it has developed wide-field OCT, enabling larger image capture crucial for examining excised tumors. The company's current S series device is already in use in several operating rooms, gathering user feedback. It is also conducting clinical trials for its next-gen B series device, integrating AI technology to enhance surgeon workflow.

While the base OCT technology isn't new, the company's innovations and AI integration represent the latest advancements.

Contact Details

Proactive Investors

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/perimeter-medical-imaging-ai-shortlisted-for-grant-funding-under-biden-cancer-moonshot-initiative-694848150

Perimeter Medical Imaging AI

comtex tracking

COMTEX_441748663/2655/2023-10-11T13:01:32